Controversies on corticosteroid therapy in hantavirus cardiopulmonary syndrome

Hantavirus cardiopulmonary syndrome is an emerging zoonosis in Argentina, which has low incidence but high death rates. No specific pharmacological therapy is available and symptomatic therapy is the only current alternative. This article presents the pathogenesis of hantavirus cardiopulmonary syndrome through a review of clinical experiences in neighbor South American countries, mainly Chile, and the experience acquired at the Infectious Diseases Hospital Francisco Javier Muñiz, Buenos Aires, Argentina. The role of early corticosteroid therapy is discussed taking into account that there is insufficient evidence favoring its use in the hantavirus cardiopulmonary syndrome.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:81

Enthalten in:

Medicina - 81(2021), 4 vom: 08., Seite 617-623

Sprache:

Spanisch

Weiterer Titel:

Controversias sobre el uso de corticoides en el síndrome cardiopulmonar por hantavirus

Beteiligte Personen:

Saúl, Pablo A [VerfasserIn]
Sánchez-Cunto, Milagro [VerfasserIn]
Gregori-Sabelli, Rosana A [VerfasserIn]
Chacón, Norberto R [VerfasserIn]
Chediack, Viviana [VerfasserIn]
Cunto, Eleonora R [VerfasserIn]

Themen:

Corticosteroids
Hantavírus
Hantavirus cardiopulmonary syndrome
Journal Article
Review

Anmerkungen:

Date Completed 31.08.2021

Date Revised 07.12.2022

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM329966235